✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

RPG Life Sciences Ltd.

RPGLIFE

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹3,964 Cr.
P/E
21.69

RPG Life Sciences Ltd.

  • RPG Life Sciences
  • Advanced Enzyme
  • Guj. Themis Biosyn
  • TJI Pharma - Small Cap

FAQs on RPG Life Sciences Ltd. Shareprice

RPG Life Sciences has given better returns compared to its competitors.
RPG Life Sciences has grown at ~34.18% over the last 7yrs while peers have grown at a median rate of 15.95%

RPG Life Sciences is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of RPG Life Sciences is 21.71, while 3 year average PE is 26.71.
Also latest EV/EBITDA of RPG Life Sciences is 24.53 while 3yr average is 16.8.

View FAQ's On Business

Growth Table

  • RPG Life Sciences Ltd.
  • Advanced Enzyme
  • Guj. Themis Biosyn

Balance Sheet

  • RPG Life Sciences Ltd.
  • Advanced Enzyme
  • Guj. Themis Biosyn

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • RPG Life Sciences Ltd.
  • Advanced Enzyme
  • Guj. Themis Biosyn

Cash Flow

  • RPG Life Sciences Ltd.
  • Advanced Enzyme
  • Guj. Themis Biosyn

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • RPG Life Sciences Ltd.
  • Advanced Enzyme
  • Guj. Themis Biosyn

Quarterly Results

  • RPG Life Sciences Ltd.
  • Advanced Enzyme
  • Guj. Themis Biosyn

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on RPG Life Sciences Ltd. Financials

Balance sheet of RPG Life Sciences is strong.
It shouldn't have solvency or liquidity issues.

The net debt of RPG Life Sciences is decreasing.
Latest net debt of RPG Life Sciences is -₹279.2 Crs as of Mar-25.
This is less than Mar-24 when it was -₹72.92 Crs.

Yes, profit is increasing.
The profit of RPG Life Sciences is ₹183 Crs for TTM, ₹183 Crs for Mar 2025 and ₹87.66 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
RPG Life Sciences latest dividend payout ratio is 21.66% and 3yr average dividend payout ratio is 27.06%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech